Could I Have Sleep Apnea? A 5-Minute Self-Check Guide (Based on the International STOP-BANG Questionnaire)

Simplified STOP-BANG 5 Questions: Am I in the High-Risk OSA Group?

STOP-BANG is an internationally validated OSA screening tool (developed at the University of Toronto) covering 8 risk factors. Below is a simplified 5-item version (1 point per affirmative; ≥ 3 = moderate-to-high risk):

Item	Description	Match?
S — Snoring	Family or bedpartner reports your snoring is audible through a closed door	Yes / No
T — Tiredness	Frequent daytime fatigue, sleepiness, or drowsy driving	Yes / No
O — Observed apneas	Someone has observed you stop breathing or gasp during sleep	Yes / No
P — Pressure	Diagnosed hypertension or currently on antihypertensives	Yes / No
BANG — body factors	BMI > 30 / age > 50 / neck > 41 cm (men) or 38 cm (women) / male sex — ≥ 2 match	Yes / No

If ≥ 3, proceed directly to a sleep specialist, pulmonologist, or ENT for further testing. Untreated OSA over years increases the risk of cardiovascular disease, stroke, erectile dysfunction, diabetes, and other comorbidities.

Typical Signs and Comorbidities in High-Risk Groups

Beyond STOP-BANG, the following signs and comorbidities warrant attention:

Morning headache, dry mouth: consequences of nocturnal hypoxia and mouth breathing.
Reduced concentration, irritability, depressed mood: chronic sleep fragmentation and hypoxia affect the CNS.
Frequent nocturia (≥ 2 times/night): OSA elevates atrial natriuretic peptide release.
Erectile dysfunction: multiple publications in The Journal of Sexual Medicine document significantly elevated ED prevalence in men with OSA.
Resistant hypertension: OSA prevalence exceeds 70% in patients with treatment-resistant hypertension.
Diabetes, atrial fibrillation, stroke history: OSA is an independent risk factor.

OSA presentations in women are often atypical — predominantly insomnia, headache, or depressed mood — and are frequently misattributed to menopause or mood disorders. Prevalence rises markedly after menopause.

If Self-Check Suggests OSA — What Next?

Self-check does not replace formal diagnosis but provides a clear starting point. Recommended pathway:

Schedule a sleep medicine, pulmonology, or ENT consultation.
Undergo PSG (polysomnography) or HSAT (home sleep apnea test) for AHI-based severity confirmation (mild 5–15, moderate 15–30, severe ≥ 30).
Discuss CPAP, OAT (oral appliance), surgery options with your care team based on severity and lifestyle.
If OAT is chosen, an OSAWELL-certified dentist must prescribe and supervise the custom fabrication workflow.
Re-evaluate at 3–6 months with follow-up PSG or overnight oximetry to confirm efficacy and titrate device settings.

OSA is a long-term management disease. The therapeutic goal is not just "no snoring" — it is reducing AHI to < 5 while improving daytime function and cardiovascular risk. The earlier you seek care, the more cardiometabolic risk you can offset.

FAQ

What STOP-BANG score indicates high risk?

On the full 8-item STOP-BANG, ≥ 5 indicates high risk (especially for severe OSA), 3–4 is moderate, and 0–2 is low. In the simplified 5-item version above, ≥ 3 warrants medical evaluation. The questionnaire is a screening tool only; diagnosis requires PSG or HSAT.

Can I just use a home sleep tracking wristband to self-diagnose?

Consumer wearables (Apple Watch, Fitbit, Garmin) can provide reference data for oxygen saturation, heart rate, and sleep stages — useful for noticing patterns and prompting medical visits — but they cannot diagnose OSA. Diagnosis requires FDA/TFDA-cleared medical devices delivering PSG or HSAT, with AHI interpreted by a sleep physician.

After OSA diagnosis, should I try CPAP or OAT first?

Depends on severity and personal preference. AASM guideline: mild-to-moderate OSA (AHI 5–30) or CPAP intolerance — OAT is mainstream; severe OSA (AHI ≥ 30) — CPAP first-line. Actual choice requires joint discussion with sleep physician and dentist based on your AHI, comorbidities, lifestyle, and adherence intent. See full comparison: OAT vs CPAP.